Intervention Review

Oral vasodilators for primary Raynaud's phenomenon

  1. Marlene Stewart*,
  2. Joanne R Morling

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 11 JUL 2012

Assessed as up-to-date: 14 MAY 2012

DOI: 10.1002/14651858.CD006687.pub3


How to Cite

Stewart M, Morling JR. Oral vasodilators for primary Raynaud's phenomenon. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD006687. DOI: 10.1002/14651858.CD006687.pub3.

Author Information

  1. University of Edinburgh, Centre for Population Health Sciences, Edinburgh, UK

*Marlene Stewart, Centre for Population Health Sciences, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK. Marlene.Stewart@ed.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 11 JUL 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sergio Toledo Valdovinos, Gregory J. Landry, Raynaud Syndrome, Techniques in Vascular and Interventional Radiology, 2014,

    CrossRef

  2. 2
    Ariane L. Herrick, Management of Raynaud’s Phenomenon and Digital Ischemia, Current Rheumatology Reports, 2013, 15, 1

    CrossRef